Abbott 2019 guidance raised

Abbott Laboratories (ABT) Q2 results: Revenues: $7,979M (+2.7%); Nutrition: $1,875M (+0.9%); Diagnostics: $1,905M (+1.7%); Established Pharmaceuticals: $1,108M (-1.8%); Medical Devices: $3,075M (+6.4%).

Net Income: $1,006M (+40.1%); EPS: $0.56 (+40.0%); Non-GAAP Net Income: $1,465M (+13.1%); Non-GAAP EPS: $0.82 (+12.3%).

2019 Guidance: GAAP EPS: $2.06 – 2.12 from $1.95 – 2.05; Non-GAAP EPS: $3.21 – 3.27 from $3.15 – 3.25.

Q3 Guidance: GAAP EPS: $0.53 – 0.55; Non-GAAP EPS: $0.83 – 0.85.

Shares are up 1% premarket.

https://seekingalpha.com/news/3478361-abbott-1-percent-q2-beat-2019-guidance-raised